This inventor holds 16 USPTO granted patents and 2 published patent applications and 7 EPO patents, primarily in Therapeutic Agents. Top assignees: Xenon Pharmaceuticals Inc., Novartis Pharma Ag, Xenon Genetics Inc.. Active years: 2004-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2004-2013
Areas of Expertise:
Title: **Innovator Spotlight: Michael D. Winther**
Introduction
Michael D. Winther is a prominent inventor based in Vancouver, Canada, known for his significant contributions to the biomedical field. With a remarkable portfolio of 16 patents, he has focused on developing innovative therapeutic agents, particularly those targeting specific diseases and conditions.
Latest Patents
One of Winther's latest patents includes "Pyridyl derivatives and their use as therapeutic agents." This patent discloses methods for treating SCD-mediated diseases or conditions in mammals, particularly humans. The methods involve administering a specialized compound of formula (I), showcasing Winther’s commitment to improving health outcomes through scientific innovation.
Career Highlights
Throughout his career, Michael D. Winther has worked with leading companies such as Xenon Pharmaceuticals Inc. and Novartis Pharma AG. His experiences in these respected organizations have shaped his knowledge and expertise in drug development and therapeutic solutions, making him a valuable asset in the field of innovation.
Collaborations
Winther has collaborated with esteemed colleagues, including Heinz W. Gschwend and Serguei Sviridov. These partnerships have contributed to advancements in research and patent developments, enhancing the potential for groundbreaking therapies that can benefit patients worldwide.
Conclusion
Michael D. Winther exemplifies the spirit of innovation with his extensive patent portfolio and collaboration with notable pharmaceutical firms. His ongoing efforts in developing therapeutic agents serve as an inspiration to aspiring inventors and a testament to the impact of dedicated research and development in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile